KATHLEEN CALNAN: Open Payments
NPI 1437291556 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 9 payments from 5 companies in 2025. Trend: 2023 $386 · 2024 $222 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $250 |
| Teva Pharmaceuticals USA, Inc. | 2 | $137 |
| Alkermes, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: COBENFY, UZEDY, ARISTADA, CAPLYTA, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
